Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
SNOAW was delisted on the 22nd of January, 2020.
3 hedge funds and large institutions have $14K invested in Sonoma Pharmaceuticals, Inc. Warrants in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
50% less funds holding
Funds holding: 6 → 3 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
99% less capital invested
Capital invested by funds: $1.27M → $14K (-$1.26M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIG
Mariner Investment Group
Harrison,
New York
|
+$9.43K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.23M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$23K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$10K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIG
1
Mariner Investment Group
Harrison,
New York
| $10K | +$9.43K | +22,127 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $3K | +$2.39K | +5,601 | +305% |
|
3
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
AFM
4
Anson Funds Management
Dallas,
Texas
| – | -$1.23M | -171,851 | Closed |
|
|
VKH
5
Virtu KCG Holdings
New York
| – | -$23K | -42,520 | Closed |
|
|
BRWA
6
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$10K | -17,500 | Closed |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$7K | -10,971 | Closed |
|
SNOAW Hedge Fund Activity: Q2 2017 in Review
3 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q2 2017, worth a combined $14K — down 99% from $1.27M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SNOAW and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Mariner Investment Group, opening a new position worth an estimated $9.43K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.23M sold.
- 3 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q2 2017, down from 6 in Q1 2017.
- Funds reported $14K of Sonoma Pharmaceuticals, Inc. Warrants stock for Q2 2017, down 99% quarter-over-quarter.
- 1 fund opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q2 2017 and 4 closed out, a net change of -3 holders.
- The largest Sonoma Pharmaceuticals, Inc. Warrants buyer in Q2 2017 was Mariner Investment Group, an estimated $9.43K added.
- The largest Sonoma Pharmaceuticals, Inc. Warrants seller in Q2 2017 was Anson Funds Management, an estimated $1.23M sold.
Based on aggregated 13F filings for Q2 2017.